维普期刊资源整合服务平台（V6.5）

114篇 您的检索式：作者名="Sledge GW"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅲ trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial(E1193) 显示文摘	Sledge GW Neuberg D Bernardo P	2003	J Clin Oncol2003，21，4：	1
2	Association of polymorphisms of angiogenesis genes with breast cancer显示文摘	Schneider BP Radovich M Sledge GW	2007	Breast Cancer Res Treat2007，111，：	1
3	Redefining the target chemotherapeutics as antiangiogenics 显示文摘	Miller KD Sweeney CJ Sledge GW	2001	J Clln Oneol2001，19，4：	1
4	Redefining the target:chemotherapeutics as antiangiogenics显示文摘	Miller KD Sweeney CJ Sledge GW	2001	Clin Oncol2001，19，4：	1
5	Redefining the target : chemotherapeutics as antiangiogenics 显示文摘	Miller KD Sweeney CJ Sledge GW	2001	J Clin Oncol2001，19，4：	1
6	Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects显示文摘	Sledge GW Jr	2002	Semin Oncol2002，29，：	1
7	Survival from first re- currence: relative importance of prognostic factors in 1015 breast cancer patients显示文摘	Clark GM Sledge GW Osborne J CK	1987	J Clin Oncol1987，5，：	1
8	Refining the target:chemotherapeutics as antiangiogenics显示文摘	MILLER KD SWEENEY CJ SLEDGE GW	2001	J Clin Oncol2001，19，10：	1
9	Phase III trial of doxorubicin,paclitaxel,and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer:an intergroup trial (E1193) 显示文摘	Sledge GW Neuberg D Bernardo P	2003	J Clin Oncol2003，21，4：	1
10	Cisplatin in the management of breast cancer 显示文摘	Sledge GW Jr Roth BJ	1989	Semin Oncol1989，16，46：	1
11	The role of angiogenesis inhibition in the treatment of breast cancer显示文摘	Sledge GW Rugo HS Burstein HJ	2006	Clin Adv Hematol Oncol2006，21，10：	1
12	Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice显示文摘	Sledg GW Qulali M Goulet R	1995	J Natl Cancer Inst1995，87，20：	1
13	Drug insight:VEGF as a therapeutic target for breast cancer显示文摘	Schneider BP Sledge GW Jr	2007	Nat Clin Pract Oncol2007，4，：	1
14	Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects显示文摘	Sledge GW	2002	Semin Oncol2002，29，311：	1
15	Phase Ⅲ trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front - line chemotherapy for metastatic breast cancer: an intergroup trial(E1193)显示文摘	Neuberg D Bernardo P	2003	J Clin Oncol2003，21，4：	1
16	Association of polymorphisms of angiogenesis genes with breast cancer显示文摘	Schneider BP Radovich M Sledge GW	2007	Cancer Res Treat2007，111，1：	1
17	Angiogenesis inhibition in the treatment of breast cancer: a review of studies presented at the 2006 san antonio breast cancer symposium显示文摘	Miller KD Sledge GW Burstein HJ	2007	Clin Adv Hematol Oncol2007，5，3：	1
18	Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193)显示文摘	Sledge GW Neuberg D Bemardo P	2003	J Clin Oncl2003，21，4：	1
19	Vascular endothelial growth factor in breast cancer:biologic and therapeutic aspects 显示文摘	Sledge GW	2002	Semin Oncol2002，29，311：	1
20	Effects of doxycycline on human prostate cancer cells in vitro 显示文摘	File RS Sledge GW Jr Roth BJ l	1998	Cancer Letter1998，127，1：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示